NASDAQ:ARTCArthroCare Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ArthroCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.56 -0.03 (-5.06 %) (As of 06/2/2020 04:00 PM ET) Add Share Today's Range$0.56Now: $0.56▼$0.5750-Day Range$1.48MA: $1.61▼$1.7652-Week Range N/AVolume2.34 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ArthroCare. Previous Next 2.5 Community Rank Outperform VotesArthroCare has received 142 “outperform” votes. (Add your “outperform” vote.)Underperform VotesArthroCare has received 142 “underperform” votes. (Add your “underperform” vote.)Community SentimentArthroCare has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote “Outperform” if you believe ARTC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ARTC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldArthroCare does not currently pay a dividend.Dividend GrowthArthroCare does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ArthroCare insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Equipment SectorN/A Current SymbolNASDAQ:ARTC Previous Symbol CUSIP04313610 CIK1005010 Webwww.arthrocare.com Phone+1-512-3913900Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive ARTC News and Ratings via Email Sign-up to receive the latest news and ratings for ARTC and its competitors with MarketBeat's FREE daily newsletter. ArthroCare (NASDAQ:ARTC) Frequently Asked Questions Has ArthroCare been receiving favorable news coverage? Headlines about ARTC stock have trended very negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ArthroCare earned a news sentiment score of -3.5 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutArthroCare. Who are some of ArthroCare's key competitors? Some companies that are related to ArthroCare include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Masimo (MASI). View all competitors. What other stocks do shareholders of ArthroCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other ArthroCare investors own include Halliburton (HAL), Nantkwest (NK), Activision Blizzard (ATVI), Arrow Electronics (ARW), ARRIS International (arrs), ArcBest (ARCB), Anadarko Petroleum (APC), American Outdoor Brands (AOBC), Amyris (AMRS) and Alcatel Lucent (ALU). Who are ArthroCare's key executives? ArthroCare's management team includes the following people: Gayle Wiley, Chief Human Resource Officer, Senior Vice PresidentJean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)Fred B. Dinger III, Senior Vice President, General Manager of ENTJames L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)Fabiana Lacerca-Allen, Independent Director (Age 47) What is ArthroCare's stock symbol? ArthroCare trades on the NASDAQ under the ticker symbol "ARTC." What is ArthroCare's stock price today? One share of ARTC stock can currently be purchased for approximately $0.56. What is ArthroCare's official website? The official website for ArthroCare is www.arthrocare.com. How can I contact ArthroCare? ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900. This page was last updated on 6/2/2020 by MarketBeat.com Staff
